PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...

PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, today announced that Bioject’s needle-free injection ...

Novel needle-free Intradermal (ID) delivery technologies provide effective alternatives to traditional Mantoux ID administration using needles. An in-depth review of 59 published scientific ...

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

The global intradermal injection market size is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from ...

WASHINGTON – Kids aren’t the only needle-phobes. A lot of adults don’t get the shots they need, including the flu vaccine, because they fear the pain. But now there is a new kind of “ouchless” flu ...

The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.

(BUSINESS WIRE )-- PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling technology, today announced that they will share the latest routine ...